Management of Metabolic Syndrome in a 60-Year-Old Woman Using a Family Medicine Approach
DOI:
https://doi.org/10.53089/medula.v15i1.1562Keywords:
Family physician, hyperuricemia, hypercholesterolemia, lifestyle intervention, metabolic syndromeAbstract
Metabolic syndrome is a cluster of risk factors including hypertension, dyslipidemia, central obesity, and insulin resistance that increase the risk of cardiovascular disease. Elderly individuals are particularly vulnerable due to physiological aging, reduced physical activity, and unhealthy dietary habits. This case report presents a comprehensive management of a 60-year-old female patient diagnosed with metabolic syndrome, consisting of hyperuricemia, hypercholesterolemia, and grade I hypertension. The patient presented to a primary care facility with complaints of shoulder pain and headache, and a sedentary lifestyle. Physical and laboratory examinations confirmed obesity class I (BMI 29.1), total cholesterol of 263 mg/dL, and uric acid level of 7.2 mg/dL. A multidisciplinary treatment approach was applied, combining pharmacological therapy (allopurinol, simvastatin, ibuprofen, and vitamin B12) with non-pharmacological interventions, including nutritional education, lifestyle modification, and aerobic exercise. Follow-up evaluations at two weeks and one month showed symptom relief, improved laboratory values, and enhanced patient knowledge and compliance. The integrated family medicine approach proved effective in improving the patient’s quality of life and awareness of long-term metabolic syndrome control.
References
Ahmed M, Khan MI, Farooq U, Rehman H. Metabolic syndrome: definition, pathogenesis, elements, and the effects of medicinal plants on its elements. J Diabetes Metab Disord. 2022;21(1):1011–22.
Anisimova AS, Alexandrov AI, Makarova NE, Gladyshev VN, Dmitriev SE. Protein synthesis and quality control in aging. Aging (Albany NY). 2018;10(12):4269–88.
Oppert JM, Bellicha A, Ciangura C. Physical activity in the management of persons with obesity. Eur J Intern Med. 2021;93:8–12.
Li L, Zhang Y, Zeng C. Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am J Transl Res. 2020;12(7):3167–81.
Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey 2007–2016. Arthritis Rheumatol. 2019;71(6):991–9.
Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (Riskesdas) 2018. Jakarta: Kementerian Kesehatan RI; 2018.
Perhimpunan Dokter Hipertensi Indonesia. Konsensus Penatalaksanaan Hipertensi 2019. Jakarta: InaSH; 2019.
Adamu K. Health-related quality of life among adult hypertensive patients on treatment in Dessie City, Northeast Ethiopia. PLoS One. 2022;17(9):e0273715.
Soran H, Schofield JD, Durrington PN. Hypercholesterolaemia – practical information for non-specialists. Arch Med Sci. 2018;14(5):1–21.
Stewart DJ, Langlois V, Noone D. Hyperuricemia and hypertension: links and risks. Integr Blood Press Control. 2019;12:43–62.
Kementerian Kesehatan RI. Penyelenggaraan pelayanan kesehatan lanjut usia di pusat kesehatan masyarakat. Jakarta: Kemenkes RI; 2017.
Song P, Wang H, Xia W, Chang X, Wang M, An L. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep. 2018;8(1):4314.
Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022;79(9):1927–36.
Ahmad MI, Masood S, Furlanetto DM, Nicolaou S. Urate crystals: beyond joints. Front Med (Lausanne). 2021;8:646806.
Fiori E, De Fazio L, Pidone C, Perone F, Tocci G, Battistoni A, et al. Asymptomatic hyperuricemia: to treat or not a threat? J Hypertens. 2022;42(1):1–16.
Mohammadi M, Ayoobi F, Khalili P, Soltani N, La Vecchia C, Vakilian A. Relation of hypertension with episodic and chronic primary headaches in Rafsanjan cohort study. Sci Rep. 2021;11:10021.
Liu Y, Chen H, Wang J, Zhou J, Wang Y, Chen J, et al. Digestion of nucleic acids starts in the stomach. Sci Rep. 2015;5:11936.
Perszyk EE, Smith KR, Wagner AR, Ford CN, Wright RA, Lowe MR. Fat and carbohydrate interact to potentiate food reward in healthy-weight but not in overweight or obese individuals. Nutrients. 2021;13(4):1333.
Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Curr Rheumatol Rep. 2014;16(2):400.
Aung T, Myung G, FitzGerald JD. Treatment approaches and adherence to urate-lowering therapy for patients with gout. Patient Prefer Adherence. 2017;11:795–800.
Vuu YM, Shahib AK, Rastegar M. The potential therapeutic application of simvastatin for brain complications and mechanisms of action. Pharmaceuticals (Basel). 2023;16(7):926.
Baltrusch S. The role of neurotropic B vitamins in nerve regeneration. Biomed Res Int. 2021;2021:9962895.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57.
Notoatmodjo S. Promosi kesehatan dan perilaku kesehatan. Jakarta: Rineka Cipta; 2012.
Juraschek SP, Yokose C, McCormick N, Miller ER, Appel LJ, Choi HK. Effects of dietary patterns on serum urate: results from a randomized trial of the effects of diet on hypertension. Arthritis Rheumatol. 2021;73(6):1014–20.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
